Previous Article | Next Article ![]()
Journal of Clinical Microbiology, June 2007, p. 2009-2010, Vol. 45, No. 6
0095-1137/07/$08.00+0 doi:10.1128/JCM.00235-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

UMR 1161 (INRA, AFSSA, ENVA), Ecole Nationale Vétérinaire d'Alfort, 7 avenue du Général de Gaulle, 94704 Maisons-Alfort Cedex, France
Received 30 January 2007/ Returned for modification 1 April 2007/ Accepted 16 April 2007
Accumulating evidence suggests that hepatitis E virus (HEV) infection is an emerging disease in regions where HEV is nonendemic. In France, the prevalence of anti-HEV antibodies in the general population has never been studied. Using blood donors' samples, we have found a prevalence of 3.20%, which is similar to that of other industrialized countries.
Published ahead of print on 25 April 2007.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»